Nachrichten zur Johnson Service Group PLC Aktie

Thursday, the FDA approved Johnson & Johnson (NYSE:JNJ) Rybrevant (amivantamab-vmjw) in combination with standard-of-care chemotherapy (carboplatin and pemetrexed) for locally…

Papiere von Johnson & Johnson halten sich seit nunmehr einer Woche im Bereich eines seit April 2022 bestehenden Abwärtstrends auf…

Die Johnson & Johnson Aktie zeigt sich in den letzten Tagen stabil und notiert aktuell bei 165,51 USD. Anleger blicken…

…

Chief Financial Officers now play a critical role in shaping corporate strategy and positioning organizations to meet future challenges. Bloombergs…

Between 2024 and 2030, the largest US pharma companies will lose patent protections on drugs that now account for $180…

Medical Technology has become a high-growth segment within the health care industry, while opening up new possibilities in patient care.…

Nach einer turbulenten Handelswoche zeigt der DAX® am Montag eine leichte Erholung, wobei er wieder über seine wichtigen 50- und…

The Global Hematologic Malignancies Market Size was Valued at USD 67.18 Billion in 2023 and the Worldwide Hematologic Malignancies Market…

Johnson & Johnson and Altria Group are two prominent dividend stocks, but I wouldnt rely on their payouts.…

Johnson & Johnson wins over longtime holdout for talc settlement, WSJ reports…

…

The Global Burn Care Market Size was Valued at USD 2.41 Billion in 2023 and the Worldwide Burn Care Market…

…

You wont find a more dependable dividend payer on Wall Street. But whether its the best stock for you depends…

The Johnson & Johnson filing seeks the FDAs approval for nipocalimab to treat generalized myasthenia gravis in a broad population…

The company hasnt performed well in recent years,…

…

Johnson & Johnson (JNJ) inks a definitive agreement to acquire V-Wave Ltd. for an upfront payment of $600 million. The…

Johnson & Johnson to acquire V-Wave in deal worth up to $1.1bn…

Johnson & Johnson gets green light for lung cancer combination treatment…

NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat die Einstufung für Astrazeneca nach veröffentlichten Fachartikeln für die anstehende…

We comment on the ongoing market sell-off, in addition to featuring new research reports on Johnson & Johnson (JNJ), T-Mobile…

…

These two healthcare companies have far more upside potential than Johnson & Johnson.…

These two healthcare companies have far more upside potential than Johnson & Johnson.…

Janssen-Cilag GmbH: Neuss (ots) - Urs Vögeli ist seit dem 1. August 2024 Vorsitzender der Geschäftsführung der Janssen-Cilag GmbH, dem…

Dublin, July 31, 2024 (GLOBE NEWSWIRE) -- The "United States Pain Management Therapeutics Market and Forecast Therapeutics (Devices…

…

The Global Regenerative Medicine Market Size was Valued at USD 31.90 Billion in 2023 and the Worldwide Regenerative Medicine Market…

Is it safe to buy Johnson & Johnson stock now?…

Tokio (www.aktiencheck.de) - Rating-Update: Narumi Nakagiri, Analystin von Daiwa Capital Markets, stuft die Aktie von Johnson & Johnson (J&J) (ISIN: US4781601046,…

…